The Effect of Antiretroviral Therapy on SIRT1, SIRT3 and SIRT6 Expression in HIV-Infected Patients

Human Immunodeficiency Virus (HIV) infection and the chronic use of combined antiretroviral therapy (cART) may affect the occurrence of certain disturbances in the body. There is growing interest in sirtuins–enzymes involved in the regulation of many metabolic processes in the organism and in the pathogenesis of many diseases which also exhibit potential antiviral activity. The aim of the study was to investigate the connection of cART to the expression of Sirtuin 1 (SIRT1), Sirtuin 3 (SIRT3) and Sirtuin 6 (SIRT6) in HIV-infected men. The plasma levels of sirtuins were measured before and one year after cART, and related to HIV viral load, lymphocytes T CD4+ and CD8+ count as well as the applied cART. The levels of sirtuins in plasma were measured in HIV-infected patients (n = 53) and the control group (n = 35) by immunoassay methods. There were statistically significant (p < 0.05) differences between SIRT6 in the HIV-infected patients before therapy and in the subgroups, depending on the count of lymphocytes T CD8+. There were significant differences in the levels of SIRT1 depending on the applied treatment regimen. The obtained results indicate the most significant changes in the expression of SIRT6 in the course of HIV infection and suggest an influence of the type of cART on the level of SIRT1, which indicates its important role in the course of HIV.     

Synthesis of Carba-NAD and the Structures of Its Ternary Complexes with SIRT3 and SIRT5

Carba-NAD is a synthetic compound identical to NAD except for one substitution, where an oxygen atom adjacent to the anomeric linkage bearing nicotinamide is replaced with a methylene group. Because it is inert in nicotinamide displacement reactions, carba-NAD is an unreactive substrate analogue for NAD-consuming enzymes. SIRT3 and SIRT5 are NAD-consuming enzymes that are potential therapeutic targets for the treatment of metabolic diseases and cancers. We report an improved carba-NAD synthesis, including a pyrophosphate coupling method that proceeds in approximately 60% yield. We also disclose the X-ray crystal structures of the ternary complexes of SIRT3 and SIRT5 bound to a peptide substrate and carba-NAD. These X-ray crystal structures provide critical snapshots of the mechanism by which human sirtuins function as protein deacylation catalysts.     

SIRT1 promotes DNA repair activity and deacetylation of Ku70

Human SIRT1 controls various physiological responses including cell fate, stress, and aging, through deacetylation of its specific substrate protein. In processing DNA damage signaling, SIRT1 attenuates a cellular apoptotic response by deacetylation of p53 tumor suppressor. The present study shows that, upon exposure to radiation, SIRT1 could enhance DNA repair capacity and deacetylation of repair protein Ku70. Ectopically over-expressed SIRT1 resulted in the increase of repair of DNA strand breakages produced by radiation. On the other hand, repression of endogenous SIRT1 expression by SIRT1 siRNA led to the decrease of this repair activity, indicating that SIRT1 can regulate DNA repair capacity of cells with DNA strand breaks. In addition, we found that SIRT1 physically complexed with repair protein Ku70, leading to subsequent deacetylation. The dominant-negative SIRT1, a catalytically inactive form, did not induce deacetylation of Ku70 protein as well as increase of DNA repair capacity. These observations suggest that SIRT1 modulates DNA repair activity, which could be regulated by the acetylation status of repair protein Ku70 following DNA damage.     

Insights on the Modulation of SIRT5 Activity: A Challenging Balance

SIRT5 is a member of the Sirtuin family, a class of deacetylating enzymes consisting of seven isoforms, involved in the regulation of several processes, including gene expression, metabolism, stress response, and aging. Considering that the anomalous activity of SIRT5 is linked to many pathological conditions, we present herein an overview of the most interesting modulators, with the aim of contributing to further development in this field.     

New synthetic approach to paullones and characterization of their SIRT1 inhibitory activity

A series of 7,12-dihydroindolo[3,2-d][1]benzazepine-6(5H)-ones (paullones) substituted at C9/C10 (Br) and C2 (Me, CF(3), CO(2)Me) have been synthesized by a one-pot Suzuki-Miyaura cross-coupling of an o-aminoarylboronic acid and methyl 2-iodoindoleacetate followed by intramolecular amide formation. Other approaches to the paullone scaffold based on Pd-catalyzed C-H activation were unsuccessful. In vitro enzymatic assay with recombinant human SIRT-1 indicated a strong inhibitory profile for the series, in particular the analogue with a methoxycarbonyl group at C2 and a bromine at C9. These compounds are, in general, inducers of granulocyte differentiation of the U937 acute leukemia cell line and cause a marked increase in pre-G1 of the cell cycle.     

Synthese und Eigenschaften einigerp-tolyl-phenylsubstituierter Di- und Trisilane und von 1,1,1,3,3,3-Hexaphenyltrisilan

The synthesis and properties of [Ph ₂ p-TolSi]₂, [Ph ₂ p-TolSi]₂SiPh ₂, [Ph ₃ Si]₂Si(p-Tol)₂, [Ph ₂ p-TolSi]₂Si(p-Tol)₂ and (SiPh ₃)₂SiH₂ are described. The silanes are identified using IR,Ra- and²⁹Si-NMR-spectroscopy.

     

Acyclische und cyclische Silylhydrazone und Hydrazonylsilane

Acyclic and Cyclic Silylhydrazones and Hydrazonylsilanes Dimethylketone-di-tert-butylmethylsilylhydrazone ( 1 ) is obtained in the reaction of the silylhydrazine and dimethylketone by condensation. Di-tert-butyldifluorosilane reacts with lithiated hydrazones to give fluorosilylhydrazones 2–4 , (CMe₃)₂SiF? NH? N = CRR′, ( 2 : R=Me, R′=CMe₃; 3 : R,R′=CHMe₂; 4 : R,R′=Ph). The bis(hydrazonyl)silane 5 , (CMe₃)₂Si(NH? N=CPh₂)₂, is formed in a molar ratio 1:2. Tris( 6 )- and tetrakis(hydrazonyl)silanes ( 7 ) are obtained from CMe₃SiF₃ ( 6 ), SiF₄ ( 7 ), and lithiated tert-butylmethylketon-hydrazone. The lithium derivatives 8–11 are formed in the reaction of 1–4 with butyllithium. Bis(silyl)hydrazones ( 12–15 ) are the result of the reaction of halogensilanes and the lithium derivatives of 1(8), 2(9) and 3(10); 12 : (CMe₃)₂SiMe(CMe₃SiF₂)-N? N=CMe₂, 13 : (CMe₃)₂MeSi(PhSiF₂)N? N=CMe₂, 14 : (CMe₃)₂SiF(Me₃Si)N? N=C(Me)(CMe₃), 15 : (CMe₃)₂SiF (SiMe₃)N? N=C(CHMe₂)₂. Saltelimination out of 10 und 11 leads to the formation of the first bis(imino)-2,2,4,4-cyclodisilazanes, 16 :[(CMe₃)₂ SiN? N=C(CHMe₂)₂]₂, 17 : [(CMe₃)₂SiN? N=CPh₂]₂. Cyclisation occurs in the reaction of 12 und 14 with tert-butyllithium, 2-silyl-1,2-diaza-3-sila-5-cyclopentenes ( 18 and 19 ) are formed. Dilithiated 1 reacts with SiF₄ to give the spirocyclic compound 20 . HF-elimination from 18 and dimerisation of the intermediate diazasilacyclopentadiens lead to the formation of the tricyclus 21 .     

Intra- und intermolekulare elektronische und Schwingungsrelaxation

Ohne Zusammenfassung     

Titan und Eisen in Titan-, Eisen- und Zirkoniumerzen und -konzentraten

Ohne Zusammenfassung     

Darstellung und strukturuntersuchungen von dimethylmetallacet- und acetimidohydrazinderivaten des galliums und indiums

Trimethylgallium and trimethylindium react with N′,N$\text{-}\text{?}$ dimethylacethydrazine and N′,N″,N′″-trimethylacetimidohydrazine, respectively, to form as a first step, monomeric dimethylmetal derivatives with five-membered ring skeletons. These heterocyclic compounds immediately add a further alkylmetal molecule. The ¹H NMR, IR and Raman spectra of these compounds are discussed and the results of X-ray structure determinations of two of the adducts are given.